Naim Ata
-
- Thyroid Disorders and Treatments 5
- Geriatrics and Gerontology top 10%
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 16
- Pathology and Forensic Medicine top 10%
- Vitamin D Research Studies 8
-
- Heart Failure Treatment and Management 8
- Cardiovascular Function and Risk Factors 6
-
- COVID-19 and healthcare impacts 10
-
- Hip and Femur Fractures 6
-
- Liver Disease Diagnosis and Treatment 6
Naim Ata
75 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 95
- Endocrinology, Diabetes and Metabolism 222
- Geriatrics and Gerontology 50
- Infectious Diseases 235
- Pathology and Forensic Medicine 188
- Cardiology and Cardiovascular Medicine 213
Countries citing papers authored by Naim Ata
This map shows the geographic impact of Naim Ata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naim Ata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naim Ata more than expected).
Fields of papers citing papers by Naim Ata
This network shows the impact of papers produced by Naim Ata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naim Ata. The network helps show where Naim Ata may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Naim Ata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 4 | |
| 9 | 2024 | 0 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 3 | |
| 12 | 2024 | 1 | |
| 13 | 2023 | 1 | |
| 14 | 2023 | 17 | |
| 15 | 2022 | 0 | |
| 16 | 2021 | 7 | |
| 17 | 2021 | 10 | |
| 18 | 2016 | 7 | |
| 19 | 2012 | 31 | |
| 20 | 2010 | 2 |
About Naim Ata
Naim Ata is a scholar working on Cardiology and Cardiovascular Medicine, Family Practice, Endocrinology, Diabetes and Metabolism, Infectious Diseases and Surgery, having authored 95 papers that have together received 1.1k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (16 papers), COVID-19 and healthcare impacts (10 papers), Vitamin D Research Studies (8 papers), Heart Failure Treatment and Management (8 papers), Hip and Femur Fractures (6 papers), Cardiovascular Function and Risk Factors (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Thyroid Disorders and Treatments (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (222 citations), Geriatrics and Gerontology (50 citations), Infectious Diseases (235 citations), Pathology and Forensic Medicine (188 citations) and Cardiology and Cardiovascular Medicine (213 citations). Naim Ata has collaborated with scholars based in Türkiye, Italy and Cambodia. Frequent co-authors include Derun Taner Ertuğrul, Bünyamin Yavuz, Metin Küçükazman, Ahmet Arif Yalçın, Kadir Okhan Akın, Kürşat Dal, Osman Çelik, Emre Tutal, Şuayıp Birinci and Onur Sinan Deveci. Their work appears in journals such as Atherosclerosis, Journal of Medical Virology, BMC Musculoskeletal Disorders, The Lancet Regional Health - Europe and Journal of Pediatric Orthopaedics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.